Tag:
Drug Safety
Latest Headlines
Latest Headlines
Medical data mining can predict adverse drug events
Researchers for the RAND Corp. have determined that it's possible to mine medical literature to find out whether studies involving particular medications can predict patient harm from those drugs.
Studies raise questions about how much drug safety info should be released
Prescription scares have caused a number of sources, including the FDA, to release a lot more prescription safety information--but could it be too much information? Several recent studies have raised
FDA may get $275 million more for staff, outsourcing
The Bush administration is asking Congress for an additional $275 million for fiscal 2009 to allow the FDA to add more workers, expand programs and technology, and perhaps most interestingly,
Studies show problems with four big-name drugs
It looks like yet another set of popular drugs are facing allegations that they pose safety risks. Drugs named this week in unfavorable studies include Fosamax, which may create heart problems for
ALSO NOTED: WellPoint exposes patient data; ED visits go up when OR trims Medicaid rolls; and much more...
> Security pros are lambasting WellPoint, which may have inadvertently allowed Web users to access data on 130,000 of its beneficiaries.
Study: Errors caused 200K+ deaths from '04 to '06
The story doesn't get any prettier the more often its told. This set of data, from the fifth annual Patient Safety in American Hospitals study, makes a point often made elsewhere--that preventable
ALSO NOTED: TN Medicaid to test e-prescribing program; NIH alerts patients of stolen personal information; and much more...
> Tennessee's Medicaid program and one of its Medicaid managed care providers have announced that they plan to kick off an e-prescribing pilot program in 13 of the state's rural counties.
Congress poised to give more power to the FDA
The U.S. House of Representatives has approved a bill designed to give the FDA more money and more authority to monitor and enforce drug safety rules. The bill, which is expected to pass the Senate
Study: Physicians dismiss complaints about statins
A recent study suggests physicians may be dismissing or minimizing patient complaints about possible side effects from statin drugs like Lipitor, Zocor and Crestor. University of California-San Diego
SPOTLIGHT: Outsiders should see FDA safety data
Some say that if outside researchers had access to drug safety data, disasters like the Vioxx scandal might have been avoided. At present, however, the FDA doesn't let outsiders see clinical trial data unless forced to do so. This secrecy can only do harm, suggests a new commentary in Health Affairs . Report
